Analysts: PharMerica Corp (PMC.N)
PMC.N on New York Stock Exchange
14.79USD
1 Aug 2013
14.79USD
1 Aug 2013
Price Change (% chg)
$0.15 (+1.02%)
$0.15 (+1.02%)
Prev Close
$14.64
$14.64
Open
$14.73
$14.73
Day's High
$14.81
$14.81
Day's Low
$14.60
$14.60
Volume
40,975
40,975
Avg. Vol
69,219
69,219
52-wk High
$16.44
$16.44
52-wk Low
$9.85
$9.85
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Hold | 0.32 | December | 2 Aug 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 1 | 1 | 1 | 1 |
| (2) OUTPERFORM | 1 | 1 | 1 | 2 |
| (3) HOLD | 4 | 5 | 5 | 4 |
| (4) UNDERPERFORM | 1 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.71 | 2.57 | 2.57 | 2.43 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 6 | 402.11 | 414.00 | 384.40 | 486.91 |
| Quarter Ending Dec-13 | 6 | 403.01 | 408.88 | 391.31 | 479.23 |
| Year Ending Dec-13 | 7 | 1,660.52 | 1,687.10 | 1,621.00 | 1,927.82 |
| Year Ending Dec-14 | 7 | 1,560.62 | 1,649.40 | 1,453.59 | 1,967.48 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 7 | 0.32 | 0.33 | 0.30 | 0.32 |
| Quarter Ending Dec-13 | 7 | 0.36 | 0.40 | 0.33 | 0.32 |
| Year Ending Dec-13 | 6 | 1.49 | 1.55 | 1.45 | 1.27 |
| Year Ending Dec-14 | 7 | 1.47 | 1.71 | 1.10 | 1.38 |
| LT Growth Rate (%) | 1 | 10.00 | 10.00 | 10.00 | 14.70 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-13 | 436.74 | 439.80 | 3.06 | 0.70 |
| Quarter Ending Dec-12 | 432.43 | 433.20 | 0.77 | 0.18 |
| Quarter Ending Sep-12 | 446.35 | 442.00 | 4.35 | 0.98 |
| Quarter Ending Jun-12 | 488.48 | 458.50 | 29.98 | 6.14 |
| Quarter Ending Mar-12 | 493.29 | 498.90 | 5.61 | 1.14 |
| Earnings (per share) | ||||
| Quarter Ending Mar-13 | 0.34 | 0.46 | 0.12 | 36.46 |
| Quarter Ending Dec-12 | 0.29 | 0.33 | 0.04 | 12.94 |
| Quarter Ending Sep-12 | 0.30 | 0.33 | 0.03 | 11.22 |
| Quarter Ending Jun-12 | 0.30 | 0.32 | 0.02 | 5.12 |
| Quarter Ending Mar-12 | 0.27 | 0.30 | 0.03 | 10.58 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 402.11 | 402.11 | 402.11 | 402.11 | 486.91 |
| Quarter Ending Dec-13 | 403.01 | 403.01 | 403.01 | 403.01 | 479.23 |
| Year Ending Dec-13 | 1,660.52 | 1,660.52 | 1,656.16 | 1,656.16 | 1,927.82 |
| Year Ending Dec-14 | 1,560.62 | 1,560.62 | 1,581.52 | 1,631.82 | 1,967.48 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 0.32 | 0.32 | 0.31 | 0.31 | 0.32 |
| Quarter Ending Dec-13 | 0.36 | 0.36 | 0.36 | 0.36 | 0.32 |
| Quarter Ending Dec-13 | 1.49 | 1.49 | 1.48 | 1.48 | 1.27 |
| Quarter Ending Dec-14 | 1.47 | 1.47 | 1.51 | 1.54 | 1.38 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 0 | 0 | 1 | 0 |
| Year Ending Dec-14 | 0 | 0 | 0 | 1 |
| Earnings | ||||
| Quarter Ending Sep-13 | 0 | 0 | 1 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 1 | 0 |
| Year Ending Dec-13 | 0 | 0 | 1 | 0 |
| Year Ending Dec-14 | 0 | 0 | 0 | 1 |
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: MacroRisk Analytics/EconomicInvestor
|
$15.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates